AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Lateral Positioning and Prone Positioning in ARDS Patients

RecruitingNAAges 18 Years - anyAllCentre Hospitalier de Bastia
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Lateral (30ยฐ) and alternating positioning (change of side every 30 minutes) carried out on specific beds, could be an alternative or complement to prone positioning (PP) in ARDS patients. The combination of lateralization in prone position has not been studied. The dynamic created by lateralization could allow better overall ventilation during PP, thus making it possible to further improve oxygenation. The main objective of this prospective, bicentric, open, single group study with repeated measures will be to demonstrate that the addition of repeated 30-minute periods of 30ยฐ lateralization improves pulmonary aeration in the supine and prone positions in patients with moderate to severe ARDS.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion criteria: * Age of at least 18 years * ARDS evolving for less than 5 days with a PaO2/FiO2 ratio (P/F ratio) \< 150 after optimization of PEEP (P/V curve, R/I ratio), curarization and without prior use of the PP since orotracheal intubation. * Obtained written consent of the patient, one of his relatives or the previously designated trusted person. As soon as possible, the patient will be informed and his written consent will be obtained * Beneficiary of health insurance coverage * Possibility of participating in any other studies whose evaluation criteria do not interfere with those of the study Non-inclusion criteria: Patients with at least one of the following criteria will not be eligible: * Refusal to participate * Pregnant, parturient or breastfeeding women * Intracranial pressure \> 30 mm Hg or cerebral perfusion pressure \< 60 mmHg * Severe chronic respiratory disease with oxygen therapy or mechanical ventilation at home (except CPAP/BIPAP for obstructive sleep apnea) * Chronic interstitial lung diseases * Patients on ECMO * Weight \> 100 kg * Severe liver disease Child-Pugh score 12-15 * Pneumothorax * SAPS II score \> 75 at inclusion * Unstable spinal fracture * Contraindications to EIT (pacemaker, implantable defibrillator, skin lesions between the 4th and 5th ribs). * Withdrawal (except for ECMO) or witholding treatment decision * Any other reason which, according to the investigator, could interfere with the evaluation of the study objectives * Person under legal protection measure (guardianship, curatorship, etc.) * Person deprived of liberty by a judiciary or administrative decision Exclusion criteria: \- Patients who will be unable to complete the 25-hour intervention due to worsening requiring ECMO, death or organizational problems will be excluded from the analysis.
๐Ÿ’Š

What it tests

  • pulmonary aeration in supine and ventral decubitus
๐Ÿ“

Where

2 sites
Bastia General Hospital
Bastia, France
North Hospital Marseille
Marseille, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy